249 related articles for article (PubMed ID: 8710741)
61. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
62. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
63. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers.
Shah PJ; Jogani VV; Mishra P; Mishra AK; Bagchi T; Misra AR
Nucl Med Commun; 2007 Aug; 28(8):653-9. PubMed ID: 17625388
[TBL] [Abstract][Full Text] [Related]
64. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
65. The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured.
Palumbo P; Lombardi F; Cifone MG; Cinque B
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):199-206. PubMed ID: 30360752
[TBL] [Abstract][Full Text] [Related]
66. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.
Bak A; Gudmundsson OS; Friis GJ; Siahaan TJ; Borchardt RT
Pharm Res; 1999 Jan; 16(1):24-9. PubMed ID: 9950274
[TBL] [Abstract][Full Text] [Related]
67. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
68. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
69. Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach.
Katneni K; Charman SA; Porter CJ
J Pharm Sci; 2007 Feb; 96(2):280-93. PubMed ID: 17051595
[TBL] [Abstract][Full Text] [Related]
70. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
71. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
72. Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.
Chiu YY; Higaki K; Neudeck BL; Barnett JL; Welage LS; Amidon GL
Pharm Res; 2003 May; 20(5):749-56. PubMed ID: 12751630
[TBL] [Abstract][Full Text] [Related]
73. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
74. Lactose oleate as new biocompatible surfactant for pharmaceutical applications.
Perinelli DR; Lucarini S; Fagioli L; Campana R; Vllasaliu D; Duranti A; Casettari L
Eur J Pharm Biopharm; 2018 Mar; 124():55-62. PubMed ID: 29258912
[TBL] [Abstract][Full Text] [Related]
75. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
76. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
77. Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer.
Yang L; Zhang H; Mikov M; Tucker IG
Mol Pharm; 2009; 6(2):448-56. PubMed ID: 19718798
[TBL] [Abstract][Full Text] [Related]
78. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
79. Effect of stereochemistry on the transport of Aca-linked beta-turn peptidomimetics across a human intestinal cell line.
Tamura K; Agrios KA; Vander Velde D; Aubé J; Borchardt RT
Bioorg Med Chem; 1997 Sep; 5(9):1859-66. PubMed ID: 9354242
[TBL] [Abstract][Full Text] [Related]
80. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells.
Hossain Z; Kurihara H; Hosokawa M; Takahashi K
Mol Cell Biochem; 2006 Apr; 285(1-2):155-63. PubMed ID: 16477371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
